Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
2,642,375
Value
$239.8M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,642,375$239.8M0.1%−1,069,868−28.8%ReducedHolders
Q1 20263,712,243$381.1M0.3%+753,065+25.4%AddedHolders
Q4 20252,959,178$370.8M0.2%+365,151+14.1%AddedHolders
Q3 20252,594,027$347.4M0.3%−743,840−22.3%ReducedHolders
Q2 20253,337,867$454.0M0.4%−169,902−4.8%ReducedHolders
Q1 20253,507,769$465.3M0.4%+427,749+13.9%AddedHolders
Q4 20243,080,020$348.4M0.3%+874,839+39.7%AddedHolders
Q3 20242,205,181$251.4M0.2%−155,055−6.6%ReducedHolders
Q2 20242,360,236$245.3M0.3%+360,898+18.1%AddedHolders
Q1 20241,999,338$227.2M0.3%+218,395+12.3%AddedHolders
Q4 20231,780,943$196.0M0.4%+550,897+44.8%AddedHolders
Q3 20231,230,046$119.1M0.3%−192,213−13.5%ReducedHolders
Q2 20231,422,259$155.1M0.3%−464,188−24.6%ReducedHolders
Q1 20231,886,447$191.0M0.4%+1,007,560+114.6%AddedHolders
Q4 2022878,887$96.5M0.2%+370,590+72.9%AddedHolders
Q3 2022508,297$49.2M0.1%−283,661−35.8%ReducedHolders
Q2 2022791,958$86.0M0.2%−47,920−5.7%ReducedHolders
Q1 2022839,878$99.4M0.2%+222,583+36.1%AddedHolders
Q4 2021617,295$86.9M0.2%−278,513−31.1%ReducedHolders
Q3 2021895,808$105.8M0.2%−1,540,659−63.2%ReducedHolders
Q2 20212,436,467$282.5M0.5%+2,180,849+853.2%AddedHolders
Q1 2021255,618$30.6M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.